South Africa’s medicine regulator, Sahpra, has registered CAB-LA, a new anti-HIV jab. But for how much will drugmaker ViiV Healthcare sell it to the government?
South Africa's medicine regulator has registered CAB-LA, a new anti-HIV jab. But for how much will drugmaker ViiV Healthcare sell it to the government? We asked them in our TV programme, Health Beat.
The Platform to Protect Whistleblowers in Africa and partners is holding a Whistleblower Protection Week; Daily Maverick is hosting a webinar on ‘My Vote Counts: Internal democracy in the ANC and the party’s upcoming elective conference’; and the Helen Suzman Memorial Lecture is taking place at.
BREAKING: The anti-HIV jab has been approved in SA, says Sahpra Here s why it will cost more than the pill – Bhekisisa bhekisisa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhekisisa.org Daily Mail and Mail on Sunday newspapers.